Blood fats and platelets research for blood clot risk
This study looks at how blood fats (lipids) interact with platelets to help understand blood clot risk and possible future treatments. It is for people over 40 without known heart or artery disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You must not have a known disease of the heart or arteries, such as narrowed or blocked blood vessels.
- You must not be taking blood thinners (antiplatelet or anticoagulant medicines).
- You must not be taking cholesterol-lowering medicines (like statins).
- You must not be taking medicines for diabetes, such as oral medicines or insulin.
- You must be willing to sign a consent form agreeing to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at how blood platelets work in people who have high levels of lipoprotein(a), a type of fat in the blood that can increase heart risk. It tests if common blood thinners (aspirin and clopidogrel) work differently in these patients.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
Hear when a new Cardio Vascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.